Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes

被引:281
作者
Madan, A
Graham, RA
Carroll, KM
Mudra, DR
Burton, LA
Krueger, LA
Downey, AD
Czerwinski, M
Forster, J
Ribadeneira, MD
Gan, LS
Lecluyse, EL
Zech, K
Robertson, P
Koch, P
Antonian, L
Wagner, G
Yu, L
Parkinson, A
机构
[1] XenoTech LLC, Lenexa, KS 66219 USA
[2] Univ Kansas, Med Ctr, Dept Surg, Kansas City, KS 66103 USA
[3] Dupont Merck Pharmaceut Co, Stine Haskell Res Ctr, Newark, DE USA
[4] Univ N Carolina, Sch Pharm, Div Pharmaceut, Chapel Hill, NC 27599 USA
[5] BYK Gulden Lomberg GmbH, D-7750 Constance, Germany
[6] Cephalon Inc, W Chester, PA USA
[7] Sepracor Inc, Marlborough, MA USA
[8] SUGEN Inc, San Francisco, CA USA
[9] Pfizer Inc, Groton, CT 06340 USA
关键词
D O I
10.1124/dmd.31.4.421
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cultured human hepatocytes are a valuable in vitro system for evaluating new molecular entities as inducers of cytochrome P450 (P450) enzymes. The present study summarizes data obtained from 62 preparations of cultured human hepatocytes that were treated with vehicles (saline or dimethylsulfoxide, 0.1%), beta-naphthoflavone (33 muM), phenobarbital (100 or 250 muM), isoniazid (100 muM) and/or rifampin (20 or 50 muM), and examined for the expression of P450 enzymes based on microsomal activity toward marker substrates, or in the case of CYP2C8, the level of immunoreactive protein. The results show that CYP1A2 activity was markedly induced by beta-naphthoflavone (on average 13-fold, n = 28 preparations), and weakly induced by phenobarbital (11.9-fold, n = 25) and rifampin (2.3-fold, n = 22); CYP2A6 activity tended to be increased with phenobarbital (n = 7) and rifampin (n = 3) treatments, but the effects were not statistically significant; CYP2B6 was induced by phenobarbital (6.5-fold, n = 13) and rifampin (13-fold, n = 14); CYP2C8 was induced by phenobarbital (4.0-fold, n = 4) and rifampin (5.2-fold, n = 4); CYP2C9 was induced by phenobarbital (1.8-fold, n = 14) and rifampin (3.5-fold, n = 10); CYP2C19 was markedly induced by rifampin (37-fold, n = 10), but relatively modestly by phenobarbital (7-fold, n = 9); CYP2D6 was not significantly induced by phenobarbital (n = 5) or rifampin (n = 5); CYP2E1 was induced by phenobarbital (1.7-fold, n = 5), rifampin (2.2-fold, n = 5), and isoniazid (2.3-fold, n = 5); and, CYP3A4 was induced by phenobarbital (3.3-fold, n = 42) and rifampin (10-fold, n = 61), but not by beta-naphthoflavone. Based on these observations, we generalize that beta-naphthoflavone induces CYP1A2 and isoniazid induces CYP2E1, whereas rifampin and, to a lesser extent phenobarbital, tend to significantly and consistently induce enzymes of the CYP2A, CYP2B, CYP2C, CYP2E, and CYP3A subfamilies but not the 2D subfamily.
引用
收藏
页码:421 / 431
页数:11
相关论文
共 64 条
[1]  
ABDELRAHMAN SM, 2000, METABOLIC DRUG INTER, P673
[2]  
Allen SW, 2001, DRUG METAB DISPOS, V29, P1074
[3]  
BULLOCK P, 1995, DRUG METAB DISPOS, V23, P736
[4]  
Chang TKH, 1997, CANCER RES, V57, P1946
[5]  
Chen JY, 1997, DRUG METAB DISPOS, V25, P1165
[6]   OMEPRAZOLE, AN INDUCER OF HUMAN CYP1A1 AND 1A2, IS NOT A LIGAND FOR THE AH RECEPTOR [J].
DAUJAT, M ;
PERYT, B ;
LESCA, P ;
FOURTANIER, G ;
DOMERGUE, J ;
MAUREL, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 188 (02) :820-825
[7]   OMEPRAZOLE IS AN ARYL HYDROCARBON-LIKE INDUCER OF HUMAN HEPATIC CYTOCHROME-P450 [J].
DIAZ, D ;
FABRE, I ;
DAUJAT, M ;
SAINTAUBERT, B ;
BORIES, P ;
MICHEL, H ;
MAUREL, P .
GASTROENTEROLOGY, 1990, 99 (03) :737-747
[8]   Lack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophylline [J].
Dilger, K ;
Zheng, ZC ;
Klotz, U .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (03) :438-444
[9]  
DONATO MT, 1995, DRUG METAB DISPOS, V23, P553
[10]  
El-Sankary W, 2001, DRUG METAB DISPOS, V29, P1499